货号：UP826982616
| 产品信息 | |
| 产品名称： | PF-04620110 |
| 中文名称： | (请以英文为准,中文仅做参考) |
| CAS号： | 1109276-89-2 |
| 分子式： | C21H24N4O4 |
| 分子量： | 396.44 |
| MDL NO： | MFCD19443642 |
| 标准纯度： | 98+% (UP826982616) |
| 沸点： | - |
| 储存： | (UP826982616) |
| Pubchem ID： | - |
| ACS编号： | - |
| InChIKey： | - |
| Clogp | - |
| 英文别名： | - |
| 中文别名 | - |
Montelukast sodium
UP253368332151767-02-1
5-Methyl-2-((2-nitrophenyl)amino)thiophene-3-carbonitrile
UP558676574138564-59-7
Etomoxir
UP735407654124083-20-1
Orphenadrine hydrochloride
UP714753035341-69-5
Sertraline hydrochloride
UP95578996379559-97-0
N-(Piperidin-4-yl)-4'-(trifluoromethyl)-[1,1'-biphenyl]-2-carboxamide
UP672380752182439-41-4
Oxcarbazepine
UP73927026128721-07-5
2',3',5'-Tri-O-acetylguanosine
UP4296560076979-94-8
4-Aminocyclohexanone
UP52383217487976-86-1
Nordihydroguaiaretic acid
UP199758732500-38-9
C188-9
UP690631459432001-19-9
1,3,5-Triisopropylbenzene
UP817555087717-74-8
NVP-BAG956
UP993705759853910-02-8
3-(Tributylstannyl)quinoline
UP525777584166114-72-3
Paroxetine hydrochloride
UP85413138078246-49-8
LCQ-908
UP236006047956136-95-1
S3I-201
UP738281727501919-59-1
TWS119
UP747990087601514-19-6
Perindopril erbumine
UP623447256107133-36-8
Clomipramine Hydrochloride
UP70989713017321-77-6
1-(4,5-Dihydrothiazol-2-yl)azetidin-3-ol
UP320672487161715-27-1
5-Nitroindole
UP4805571116146-52-7
Eltrombopag Olamine
UP398969610496775-62-3
Lenalidomide hemihydrate
UP386644245847871-99-2
Epoxy vinyl ester resin
UP8529786922N/A
1-Methyl-4-nitro-2-(trifluoromethyl)benzene
UP96365762089976-12-5
2,4-Dichloro-3-(dichloromethyl)-1-fluoro-5-(trichloromethyl)benzene
UP317763635214774-60-4
Paricalcitol
UP690733926131918-61-1
1,3-Diiodo-5,5-dimethylhydantoin
UP4545749132232-12-4
MI 2 MALT1 inhibitor
UP2568173211047953-91-2
BLU-554
UP3989868711707289-21-1
Ezatiostat hydrochloride
UP892215471286942-97-0
Fmoc-Val-Wang resin 100-200 mesh, 1% DVB
UP4903723334N/A
(24R)-MC 976
UP893832579112828-09-8
Duloxetine hydrochloride
UP735219185136434-34-9
Toll-like receptor modulator
UP619058910926927-42-6
Tolbutamide
UP21391108764-77-7
Butane-1,2,3,4-tetracarboxylic acid
UP7621679061703-58-8
(2R,3S,4R,5R)-5-((Benzoyloxy)methyl)-3-fluorotetrahydrofuran-2,4-diyl dibenzoate
UP65354509197614-43-2
Amlexanox
UP23527655368302-57-8
BMX-IN-1
UP9053298011431525-23-3
2-(2-Fluoro-[1,1'-biphenyl]-4-yl)-2-hydroxypropanoic acid
UP85977541261466-95-3
4-Acetamido-2,2,6,6-tetramethylpiperidine 1-oxyl
UP23446494514691-89-5
3-(Thiophen-2-yl)benzoic acid
UP83092128529886-63-3
ASP5878
UP2496383031453208-66-6
Ganoderol B
UP777604276104700-96-1
Crizotinib
UP538608183877399-52-5
Alacepril
UP12904198274258-86-9
1,2-Bis(2-(4,5-dihydro-1H-imidazol-2-yl)propan-2-yl)diazene dihydrochloride
UP28552205327776-21-2
SU5402
UP614524272215543-92-3
DGAT1-IN-1
UP4282726671449779-49-0
2-Cyclohexylethylamine hydrochloride
UP8260686665471-55-6
AZD1981
UP793046696802904-66-1
Pexidartinib
UP7440864661029044-16-3
CHIR-99021 Monohydrochloride
UP7402869221797989-42-4
FAAH inhibitor 1
UP385749850326866-17-5
Methyl 4-amino-3-methoxybenzoate
UP42582073641608-64-4
Melatonin
UP27516097673-31-4
tert-Butyl 4-(6-((7-cyclopentyl-6-(dimethylcarbamoyl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-ca
UP5161169261374639-78-7
(3R,4R,5R)-3,4-Dihydroxy-5-(hydroxymethyl)dihydrofuran-2(3H)-one
UP60477984315384-37-9
Di-tert-butyl iminodicarboxylate
UP23514888051779-32-9
Voxtalisib
UP782853755934493-76-2
3-Chloropropyl 4-methylbenzenesulfonate
UP912829952632-02-0
(8S,13S,14S)-13-Methyl-1,2,6,7,8,12,13,14,15,16-decahydrospiro[cyclopenta[a]phenanthrene-3,2'-[1,3]dioxolan]-17(4H)-one
UP2925562985571-36-8
VLX1570
UP1725679211431280-51-1
ATR-101 Hydrochloride
UP383730193133825-81-7
Hydralazine hydrochloride
UP228869440304-20-1
RG7112
UP164978194939981-39-2
(2R,3R)-3-((R)-1-((tert-Butyldimethylsilyl)oxy)ethyl)-4-oxoazetidin-2-yl acetate
UP74301492276855-69-1
2-Deoxy-2-fluoro-alpha-D-arabinofuranosyl bromide 3,5-dibenzoate
UP85958149297614-44-3
Dimethyl 2-(4-bromophenyl)malonate
UP719868029149506-35-4
PF-04620110
UP8269826161109276-89-2